AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NOVO RESOURCES CORP-CDI

0.110

+0.0054.76%

Volume:5.01K

Turnover:551.00

Market Cap:39.01M

PE:-1.49

High:0.110

Open:0.110

Low:0.110

Close:0.105

Loading ...

Overview Company News Filings

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires Live

Novo Resources Corp. Business Review

Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday

MT Newswires Live

Novo Nordisk Jumps After Ozempic Decidedly Beats. But 'Periodic Supply Constraints' Expected.

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live

Market Chatter: Novo Nordisk Foundation Won't Step In to Replace US Aid for Health Sector

MT Newswires Live

What To Expect in the Markets This Week

Akero Therapeutics Stock Doubles on Liver Disease Drug Trial Results

European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading

MT Newswires Live

US Equities Markets Fall Friday as Investors Assess Inflation, Consumer Sentiment

MT Newswires Live

Sector Update: Health Care Stocks Higher Friday Afternoon

MT Newswires Live

Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week

MT Newswires Live

Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results

Sector Update: Health Care Stocks Decline Premarket Friday

MT Newswires Live

S&P 500 Gains and Losses Today: Intel Stock Soars as Takeover Speculation Spreads

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires Live

Top Midday Stories: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks; Supreme Court Allows TikTok Ban to Take Effect

MT Newswires Live

European Equities Traded in the US as American Depositary Receipts Edge Higher Friday

MT Newswires Live

Novo Nordisk Says Trial of Higher Dose Semaglutide Achieved Primary Endpoint

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVO.AU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","market":"AU","secType":"STK","nameCN":"NOVO RESOURCES CORP-CDI","latestPrice":0.11,"timestamp":1746166320000,"preClose":0.105,"halted":0,"volume":5010,"delay":0,"nameEN":"NOVO RESOURCES CORP-CDI","floatShares":314709406,"shares":354630279,"eps":-0.07363573632050606,"marketStatus":"Market Closed","change":0.005,"latestTime":"05-02 16:12:00 AEST","open":0.11,"high":0.11,"low":0.11,"amount":551,"amplitude":0,"askPrice":0.115,"askSize":11730,"bidPrice":0.1,"bidSize":523571,"shortable":3,"etf":0,"ttmEps":-0.07363573632050606,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746403200000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1694268000000,"exchange":"ASX","adjPreClose":0.105,"openAndCloseTimeList":[[1746144000000,1746165600000]],"volumeRatio":0.01476194377485564,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVO.AU\",,,,,undefined,":{"symbol":"NVO.AU","floatShares":314709406,"roa":"-13.14%","roe":"-30.09%","lyrEps":-0.073636,"volumeRatio":0.01476194377485564,"shares":354630279,"dividePrice":0,"high":0.11,"amplitude":0,"preClose":0.105,"low":0.11,"week52Low":0.081,"pbRate":"0.50","psRate":"13.92","week52High":0.16,"institutionHeld":0,"latestPrice":0.11,"committee":0.956174,"eps":-0.07363573632050606,"divideRate":0,"volume":5010,"delay":0,"ttmEps":-0.07363573632050606,"open":0.11,"prevYearClose":0.094,"prevWeekClose":0.12,"prevMonthClose":0.115,"prevQuarterClose":0.098,"fiveDayClose":0.12,"twentyDayClose":0.099,"sixtyDayClose":0.09},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVO.AU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509230968","title":"Sector Update: Health Care Stocks Rise in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2509230968","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509230968?lang=en_us&edition=fundamental","pubTime":"2025-02-06 02:58","pubTimestamp":1738781908,"startTime":"0","endTime":"0","summary":"Health care stocks were higher Wednesday afternoon, with the NYSE Health Care Index rising 1.2% and the Health Care Select Sector SPDR Fund  up 0.9%.The iShares Biotechnology ETF  climbed 2.2%.In corporate news, Boston Scientific  reported stronger-than-expected Q4 sales amid a sharp gain in its cardiovascular segment. The stock rose 1.7%.UnitedHealth Group  shares fell 1.6% following a now-deleted post from investor Bill Ackman on X questioning the company's profitability and saying that he would short its stock, Bloomberg reported.Novo Nordisk  shares rose 5%. The company reported Q4 earnings of 6.34 Danish kroner  per share, exceeding FactSet analyst consensus of 5.96 kroner.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1506573853.SGD","BK4504","LU1720051017.SGD","LU1914381329.SGD","LU1989771016.USD","XLV","LU1064131342.USD","LU0965509010.AUD","LU0738911758.USD","LU0345769631.USD","LU0795875086.SGD","LU1989772840.SGD","LU2357305700.SGD","LU0187121727.USD","LU0048584097.USD","NVO.AU","LU0545039389.USD","NVO","BSX.AU","LU1037948897.HKD","IE0005OL40V9.USD","IE00BZ1G4Q59.USD","LU2125154935.USD","IBB","IE00B19Z3B42.SGD","LU0354030511.USD","LU0154236417.USD","LU0976567544.SGD","LU2089284900.SGD","LU0820562030.AUD","LU1791710582.SGD","LU0683600562.USD","LU0234572021.USD","LU1988902786.USD","LU2461242641.AUD","LU0114720955.EUR","LU2324357040.USD","UNH","LU2125154778.USD","LU2506952097.USD","SG9999017495.SGD","BSX","LU1551013425.SGD","LU1267930730.SGD","LU1093756168.USD","IE00BJJMRX11.SGD","LU1814569148.SGD","LU1551013342.USD","IE00B19Z8X17.USD","LU0128525929.USD"],"gpt_icon":1},{"id":"2509287750","title":"Novo Resources Corp. Business Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2509287750","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509287750?lang=en_us&edition=fundamental","pubTime":"2025-02-05 23:05","pubTimestamp":1738767900,"startTime":"0","endTime":"0","summary":"Gold in soil geochemistry and main prospects of the Tabba Tabba Shear Corridor. Balla Balla Project geology showing the Sholl Shear Zone and complex folded stratigraphy. Belltopper Gold Project location map with regional gold occurrences and major structures . Location of Priority Tenements adjacent to Azure Minerals’ Andover Lithium – Nickel Project.Three new high prospectivity farm-in/JV deals in December 2024, strengthening Novo’s high-quality, Australian based exploration portfolio.Direct pegging by Novo of six new exploration licenses .The Toolunga Project is underexplored with prospectivity for precious and base metal discovery and aligns with Novo’s exploration strategy targeting > 1 Moz Au potential.De Grey Mining  has satisfied it’s $7 million minimum expenditure commitment in September 2024 and have committed to a further spend of A$18 million by June 30, 2027, to earn 50% in the Becher Project. Egina is located near De Grey’s 13.6 Moz Hemi Gold Project5.Sale of remaining 20%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-resources-corp-business-review-150500126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MHC.AU","NST.AU","MRE.AU","BK4545","IP","SCM","SQM","AZS.AU","BK4109","DEG.AU","LU1861219969.SGD","NVO.AU","BK4136","LU1861214812.USD","XKO.AU","LU0505663152.USD","XJO.AU","XAO.AU","TG1.AU","BK7507","BK4585","EGC","LU0072463663.USD","LU0572108347.SGD","LU2463526074.USD","KM1.AU","GBZ.AU","BK7104","BK7504","BK4135","BK7095","PLS.AU","SXG.AU","BK4096","BK4588","BK4093","KZR.AU","AC","BK7506"],"gpt_icon":0},{"id":"2509851281","title":"Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2509851281","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509851281?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:08","pubTimestamp":1738764487,"startTime":"0","endTime":"0","summary":"Health care stocks were leaning higher premarket Wednesday, with The Health Care Select Sector SPDR Fund  up 0.2% and the iShares Biotechnology ETF  inactive.GSK  shares were up 6.4% after the company reported Q4 earnings and sales that topped analyst estimates.Novo Nordisk  shares rose 4% after the company reported higher Q4 earnings and sales.Bio-Techne  shares were up 4.8% after the company reported higher fiscal Q2 adjusted earnings and net sales.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z6F94.USD","LU1093756168.USD","IE00BZ1G4Q59.USD","NVO","XLV","LU0154236417.USD","IE00B64QTZ34.USD","GSK.UK","BK4121","BK4588","NVO.AU","BK4007","TECH","TECH.AU","BK4585","BK4581","GSK","BK4599","IE0034390439.USD","BK4532","LU1829250122.USD","BK7104","IBB","IE00BKVL7J92.USD","LU1093756325.SGD"],"gpt_icon":1},{"id":"2509528197","title":"Novo Nordisk Jumps After Ozempic Decidedly Beats. But 'Periodic Supply Constraints' Expected.","url":"https://stock-news.laohu8.com/highlight/detail?id=2509528197","media":"Blockhead","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509528197?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:51","pubTimestamp":1738763513,"startTime":"0","endTime":"0","summary":"Novo Nordisk stock jumped Wednesday on better-than-expected fourth-quarter sales, helped by an Ozempic beat.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2024/01/Stock-NovoNordisk-Denmark-company-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2024/01/Stock-NovoNordisk-Denmark-company-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/novo-nordisk-stock-novo-nordisk-earnings-q4-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4007","BK7104","IE00BKVL7J92.USD","LU1093756168.USD","NVO.AU","LU1093756325.SGD","BK4588","IE00BZ1G4Q59.USD","NVO","LU0154236417.USD","BK4585","BK4532","BK4599"],"gpt_icon":1},{"id":"2509466683","title":"European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509466683?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:10","pubTimestamp":1738685450,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.50% to 1,356.26 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion Biotech , which soared 36.3%, followed by biopharmaceutical company DBV Technologies , which rose 10%. They were followed by financial services companies Banco Bilbao Vizcaya Argentaria  and Banco Santander , which were up 3.3% and 3.6%, respectively.The decliners from continental Europe were led by medical device maker EDAP TMS , which fell 1.2%, followed by consumer goods company Unilever  and pharmaceutical company Novo Nordisk , which were down 0.4% and 0.1% respectively.From the UK and Ireland, the gainers were led by Akari Therapeutics  and biopharmaceutical companies TC Biopharm , which rose 5.9% and 3.3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group  and Verona Pharma , which increased 2% and 1% respectively.The","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","SAN","ULVR.UK","BDRX","NCNA","BK7104","EDAP","BK4585","BK4139","BK4007","BK7142","SAN.AU","BK4132","IE00BZ1G4Q59.USD","LU1093756168.USD","TCBP","VOD","AFG","BK4117","NVO","IE00BKVL7J92.USD","BK4107","BK4505","BK4599","VRNA","MREO","BK4532","BK4521","BK4592","BK4183","AKTX","BBVA","LU1093756325.SGD","DBVT","LU0124676726.USD","NVO.AU","LU0689626769.HKD","BK4207","BK4588","EVAX","BK4082"],"gpt_icon":1},{"id":"2508144133","title":"Market Chatter: Novo Nordisk Foundation Won't Step In to Replace US Aid for Health Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2508144133","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508144133?lang=en_us&edition=fundamental","pubTime":"2025-02-03 23:09","pubTimestamp":1738595345,"startTime":"0","endTime":"0","summary":"Novo Nordisk  owner Novo Nordisk Foundation will not step in to support health and humanitarian organizations affected by a freeze on US international aid, and will continue to concentrate on its core non-communicable disease program, Reuters reported Monday, citing an official.The foundation will focus on funding research for treatments for heart disease, diabetes, and risk factors like obesity, the report said.Novo Nordisk Foundation did not immediately respond to a request for comment from MT Newswires.Price: 82.64, Change: -1.81, Percent Change: -2.14","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK7104","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","BK4532","IE00BZ1G4Q59.USD","NVO","NVO.AU","BK4599","LU1093756325.SGD","LU1093756168.USD","BK4588"],"gpt_icon":1},{"id":"2508630182","title":"What To Expect in the Markets This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2508630182","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508630182?lang=en_us&edition=fundamental","pubTime":"2025-02-02 18:00","pubTimestamp":1738490400,"startTime":"0","endTime":"0","summary":"Earnings from tech, media, and pharmaceutical firms could be in the spotlight this week, with Google parent Alphabet  and Amazon  set to report, along with Disney  and weight-loss drugmakers Novo Nordisk  and Eli Lilly .As the Federal Reserve watches the strength of the labor market, the January employment report is scheduled for Friday, with jobless claims and private sector payrolls also due for release this week. Several Fed officials are set to deliver remarks as well.Senior Loan Officer Opinion Survey on Bank Lending Practices . Atlanta Fed President Raphael Bostic is scheduled to deliver remarks. Palantir , Equity Residential , and Tyson Foods  are scheduled to report earnings. San Francisco Fed President Mary Daly and Atlanta Fed President Raphael Bostic are scheduled to deliver remarks. Chicago Fed President Austan Goolsbee is scheduled to deliver remarks. Novo Nordisk , Walt Disney , Qualcomm , Arm Holdings , Uber Technologies , and MicroStrategy  are scheduled to report earni","market":"fut","thumbnail":"https://www.investopedia.com/thmb/uu_OqHrFAaX-LvlHoFvt9c-gsvs=/5000x3333/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2166130918-50c04a338cd4480c94e44de0f875beca.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/uu_OqHrFAaX-LvlHoFvt9c-gsvs=/5000x3333/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2166130918-50c04a338cd4480c94e44de0f875beca.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/what-to-expect-in-the-markets-this-week-8783286","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["EQR.AU","MSTR.AU","BK4533","US7Y.BOND","PLTR","AMZN","PFE","COP","DIS","GOOG","US3Y.BOND","AMD","EQR","PEP","AMGN","AZN","CBOE","NVO","US12M.BOND","US30Y.BOND","NVO.AU","LU1883839398.USD","TSN","GOOGL","MRK","LLY","RACE","US2Y.BOND","BK4576","PFE.AU","SPOT","ARM.AU","AMD.AU","TSN.AU","US5Y.BOND","LU0708994859.HKD","US6M.BOND","BMY","PM","US10Y.BOND","USAW.SI","HON","USJW.SI"],"gpt_icon":1},{"id":"2506552588","title":"Akero Therapeutics Stock Doubles on Liver Disease Drug Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2506552588","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506552588?lang=en_us&edition=fundamental","pubTime":"2025-01-28 00:27","pubTimestamp":1737995257,"startTime":"0","endTime":"0","summary":"Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.The drug, known as EFX, helped reverse cirrhosis of the liver in patients with metabolic dysfunction-associated steatohepatitis .CEO Dr. Andrew Cheng said EFX has \"transformational potential\" in fighting the disease.Shares of Akero Therapeutics  doubled Monday when the pharmaceutical firm that focuses on metabolic illnesses reported positive results from a study of its experimental treatment for liver disease.The company said a 96-week Phase 2b study ofthose afflicted with cirrhosis caused by metabolic dysfunction-associated steatohepatitis  and given a 50mg dosage of its drug efruxifermin  showed that 39% experienced reversal of cirrhosis with no worsening of MASH. That compares to just 15% of those given placebo.Akero noted that a subgroup of patients who were not on GLP-1 weight-loss medicines, such as Novo Nordisk's  Wegovy and Eli Lilly","market":"fut","thumbnail":"https://www.investopedia.com/thmb/bjuORyMW_ZCng1ZoL1sKqOvM4Kk=/1779x546/filters:no_upscale():max_bytes(150000):strip_icc()/Akero-logo-color-861f5338b8ed4e4d8e187cf4a1d52d62.png","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/bjuORyMW_ZCng1ZoL1sKqOvM4Kk=/1779x546/filters:no_upscale():max_bytes(150000):strip_icc()/Akero-logo-color-861f5338b8ed4e4d8e187cf4a1d52d62.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/akero-therapeutics-stock-doubles-on-liver-disease-drug-trial-results-8780840","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["LU1551013342.USD","LU1814569148.SGD","LU2106854487.HKD","LU0820561818.USD","LLY","LU0097036916.USD","BK4585","SG9999014898.SGD","SG9999015945.SGD","BK7104","LU2237443622.USD","BK4533","LU2211815571.USD","LU2361044865.SGD","LU1548497426.USD","LU0820561909.HKD","SGXZ31699556.SGD","BK4123","SG9999014906.USD","LU1061106388.HKD","LU0456855351.SGD","LU2237443895.HKD","LU0198837287.USD","AKRO","LU1035775433.USD","LU1983299246.USD","BK4139","NVO.AU","LU2461242641.AUD","LU1868837300.USD","IE00B2B36J28.USD","LU0882574139.USD","LU1057294990.SGD","LU1712237335.SGD","SG9999015952.SGD","BK4534","LU0109391861.USD","LU1868836757.USD","LU1720051017.SGD","BK4516","LU1551013425.SGD","NVO","IE00BKVL7J92.USD","LU2324357040.USD","LU0238689110.USD","LU2491049909.HKD","EFX","LU0943347566.SGD","LU0354030438.USD","LU0289739699.SGD"],"gpt_icon":1},{"id":"2506301200","title":"European Equities Traded in the US as American Depositary Receipts Tread Water in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2506301200","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506301200?lang=en_us&edition=fundamental","pubTime":"2025-01-28 00:09","pubTimestamp":1737994173,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were treading water late Monday morning, edging 0.04% higher to 1,357.59 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion Biotech  and telecommunications company Ericsson , which rose 5% and 3.6%, respectively. They were followed by medical device maker EDAP  and biopharmaceutical company DBV Technologies , which were up 3.1% and 2.8%, respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and internet browser company Opera , which dropped 3.8% and 3.3%, respectively. They were followed by biopharmaceutical company Grifols  and pharmaceutical company Novo Nordisk , which lost 1.8% and 1.2%, respectively.From the UK and Ireland, the gainers were led by consumer goods company British American Tobacco  and biopharmaceutical company Bicycle Therapeutics , which increased 3.2% and 2.9%, respectively. They were follow","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GRFS","BK4515","SLN","87807D608","EDAP","BK7062","BK4591","BK4554","BK4117","BK4585","LU1829250122.USD","ERIC","BK4020","BK4107","NVO.AU","BK4141","BK4599","LU1093756325.SGD","GSK.UK","BK4588","AFG","BK4007","IE00BKVL7J92.USD","EVAX","GSK","SQNS","IE00BZ1G4Q59.USD","OPRA","LU1093756168.USD","BK4139","BK4082","BK4075","BK7104","BTI","BCYC","BDRX","DBVT","TCBP","TRIB","LU0154236417.USD","BK4532","NCNA","BTI.AU","BK4023"],"gpt_icon":1},{"id":"2506182708","title":"US Equities Markets Fall Friday as Investors Assess Inflation, Consumer Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2506182708","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506182708?lang=en_us&edition=fundamental","pubTime":"2025-01-25 05:03","pubTimestamp":1737752600,"startTime":"0","endTime":"0","summary":"US benchmark equity indexes fell Friday as markets evaluated the latest economic data, including a survey showing a drop in consumer sentiment and an increase in inflation expectations.* US consumer s","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0985320562.USD","LU2129689431.USD","IE00BKVL7J92.USD","LU1066053197.SGD",".IXIC","QLD",".SPX","IE0008368304.USD","SGXZ31699556.SGD","DXD","SQQQ","SPGI","DJX","BK4599","LU1823568750.SGD","IE00BZ199S13.USD","LU0354030438.USD","DDM","LU2111349929.HKD","ISBC","SG9999018865.SGD","LU0557290698.USD","NQmain","PSQ","TQQQ","LU0545039389.USD","MNQmain","LU1046421795.USD","TSYW.SI","DOG","SG9999011175.SGD","BK4588","NVO","BK4548","TXN","BK4585","QID","BK4581","BK4112","USAW.SI","SDOW","NVIW.SI","NVO.AU","UDOW",".DJI","SG9999014880.SGD","LU1721428933.USD","GB00BDT5M118.USD","USJW.SI"],"gpt_icon":1},{"id":"2506689123","title":"Sector Update: Health Care Stocks Higher Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2506689123","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506689123?lang=en_us&edition=fundamental","pubTime":"2025-01-25 02:53","pubTimestamp":1737744808,"startTime":"0","endTime":"0","summary":"Health care stocks were rising Friday afternoon, with the NYSE Health Care Index adding 0.8% and the Health Care Select Sector SPDR Fund  up 0.3%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Novo Nordisk  shares jumped 8.2% after it said Friday that its investigative weight loss drug amycretin led to a body weight reduction of up to 22% in an early-stage trial.HCA Healthcare  reported Q4 adjusted earnings Friday of $6.22 per diluted share, up from $5.90 a year earlier. Revenue for the quarter was $18.29 billion, up from $17.30 billion a year earlier. Its shares were shedding 3.5%.Allurion Technologies  shares surged past 122%. The company said Friday that it signed a definitive agreement with institutional investors for the sale of 1.24 million common shares at $6 per share through a registered direct offering for proceeds of $7.4 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999014005.SGD","LU1119994496.HKD","IE00BKVL7J92.USD","LU1489326972.SGD","LU0648001328.SGD","LU0980610538.SGD","LU0114720955.EUR","LU0203345920.USD","LU0211328371.USD","HCA","LU0154236417.USD","BK4599","BK4185","SG9999014013.SGD","LU1093756325.SGD","LU0068578508.USD","IE00BZ1G4Q59.USD","LU0211327993.USD","IE00B775SV38.USD","LU0985489474.SGD","LU0187121727.USD","BK4532","BK4007","BK4504","LU2244417387.USD","LU0203347892.USD","LU1267930490.SGD","BK7104","LU0029864427.USD","LU0868494617.USD","BK4588","NVO","ALUR","BK4192","BK4585","IBB","BK4581","LU1084165304.USD","IE00B3S45H60.SGD","LU1150488218.USD","LU1150488135.SGD","LU1201861249.SGD","LU1261432733.SGD","LU1093756168.USD","NVO.AU","XLV","LU0310800379.SGD","LU0433182093.SGD","LU0878866978.SGD","LU0310799852.SGD"],"gpt_icon":1},{"id":"2506657895","title":"Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2506657895","media":"Investopedia","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506657895?lang=en_us&edition=fundamental","pubTime":"2025-01-25 00:25","pubTimestamp":1737735902,"startTime":"0","endTime":"0","summary":"Allurion Technologies said it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves muscle mass in patients.The company noted that those using GLP-1 treatments lose muscle mass, while those that received its product maintained and sometimes gained muscle mass.Shares tripled on the news, but still remain significantly lower over the past year.Shares of Allurion Technologies  tripled Friday as the maker of the Allurion Gastric Balloon weight-loss device looked to take advantage of the booming obesity drug market.The company announced it would begin a study to see if its gastric balloon, combined with popular GLP-1 medicines like Novo Nordisk's  Wegovy and Eli Lilly's  Mounjaro, could improve muscle mass and overall body composition in patients.The company noted that previous research showed those who used GLP-1 treatments \"demonstrated reductions in lean mass of approximately 40% as a proportion of total weight lost.\" ","market":"sg","thumbnail":"https://www.investopedia.com/thmb/dwy4LSYyu5-QNDe6YW8KgycXehg=/6000x4000/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2178012636-44572e0fb5bd4412a0b07f795b71c4c8.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/dwy4LSYyu5-QNDe6YW8KgycXehg=/6000x4000/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2178012636-44572e0fb5bd4412a0b07f795b71c4c8.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/allurion-technologies-stock-triples-on-plan-to-test-gastric-balloon-with-obesity-drugs-8779725","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["LU0882574139.USD","LU0106261372.USD","LU1551013342.USD","SG9999001176.SGD","SG9999018865.SGD","LU0417517546.SGD","LU0823416689.USD","NVO.AU","SGXZ31699556.SGD","LU2237443549.SGD","BK4192","IE0004445239.USD","LU0198837287.USD","LU0943347566.SGD","IE00B2B36J28.USD","LU1868836591.USD","LU1267930730.SGD","LU1548497426.USD","ALUR","LU2063271972.USD","LU0689472784.USD","LU0289739699.SGD","SGXZ81514606.USD","LU0203202063.USD","LU0058720904.USD","LU0672654240.SGD","IE00BFTCPJ56.SGD","LU2461242641.AUD","LU2264538146.SGD","LU2265009873.SGD","LU0820561818.USD","SG9999014914.USD","SGXZ99366536.SGD","NVO","LU2237443978.SGD","LU2361045086.USD","LU1366192091.USD","LU2468319806.SGD","BK7104","IE00BKVL7J92.USD","LU0354030438.USD","LU0256863811.USD","LU1023059063.AUD","LU0640476718.USD","BK4588","BK4007","LU2361044949.HKD","LLY","LU1035775433.USD","LU0385154629.USD"],"gpt_icon":1},{"id":"2506700867","title":"European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gains 2% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2506700867","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506700867?lang=en_us&edition=fundamental","pubTime":"2025-01-25 00:13","pubTimestamp":1737735218,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking higher late Friday morning, gaining 0.53% to 1,358.93 on the S&P Europe Select ADR Index, and raising the week's return","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4515","LU0320765646.SGD","SHEL","BK4020","IHG","BK4169","TCBP","AMRN","GRFS","LU0098860793.USD","MREO","BK4505","SQNS","AFG","BK7104","EVAX","IE00BMPRXN33.USD","AKTX","MTLS","BK4588","BK4546","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4007","BK4532","DGE.UK","NOK","NVO.AU","BK4599","AUTL","IE00BMPRXR70.SGD","BK4117","BK4142","BK4585","TRVG","LU0154236417.USD","87807D608","BK4139","LU0300736062.USD","LU0300736492.USD","BK4141","BK4554","BK4077","BK4201","DEO","BK4023","BK4591","LU1093756168.USD","NVO","ERIC","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2505629258","title":"Novo Nordisk Stock Jumps on Early Stage Weight-Loss Drug Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2505629258","media":"Investopedia","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505629258?lang=en_us&edition=fundamental","pubTime":"2025-01-24 22:41","pubTimestamp":1737729669,"startTime":"0","endTime":"0","summary":"Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.The maker of Ozempic and Wegovy said that its Phase 1b/2a trial showed people achieved weight loss from a mean baseline body weight of 92.7 kg  in three different maintenance doses, while those treated with placebo gained weight.Novo Nordisk shares have been trending lower since September on slowing sales and increasing competition in the weight-loss drug market.Novo Nordisk's  U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for its amycretin weight-loss drug.The maker of Ozempic and Wegovy said that its Phase 1b/2aclinical trial showed people achieved weight loss from a mean baseline body weight of 92.7 kg  in three different maintenance doses, while those treated with placebo gained weight. In the highest dosage, 20mg, participants lost 22% of body weight after 36 weeks, whil","market":"sg","thumbnail":"https://www.investopedia.com/thmb/FJTPFL2uR0SaFpZiHrxF5DFzMNw=/5615x3743/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2186511013-35d19a76166947a8a692d8009b279682.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/FJTPFL2uR0SaFpZiHrxF5DFzMNw=/5615x3743/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2186511013-35d19a76166947a8a692d8009b279682.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/novo-nordisk-stock-jumps-on-early-stage-weight-loss-drug-trial-results-8779639","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["BK4585","LLY","LU0096364046.USD","LU1023059063.AUD","LU1093756325.SGD","GB00BDT5M118.USD","LU0689472784.USD","NVO.AU","LU0114720955.EUR","LU0061475181.USD","LU1093756168.USD","LU0708995401.HKD","LU2237443382.USD","LU0198837287.USD","LU0823416689.USD","LU2237443895.HKD","LU1868837136.USD","LU2491049909.HKD","LU0238689110.USD","LU2237443622.USD","LU0820561909.HKD","LU1623119135.USD","LU2264538146.SGD","NVO","BK4007","LU1127390331.HKD","LU0203202063.USD","SSI","SG9999018865.SGD","LU1548497426.USD","SG9999001176.USD","BK4532","LU1868836591.USD","LU2106854487.HKD","LU2361045086.USD","LU1983299246.USD","LU0640476718.USD","LU2237438978.USD","LU2468319806.SGD","LU2602419157.SGD","LU0820561818.USD","LU2237443549.SGD","LU2237443465.HKD","IE00BK4W5L77.USD","BK4516","IE0009355771.USD","SG9999014906.USD","LU1069344957.HKD","LU0079474960.USD","LU1720051017.SGD"],"gpt_icon":1},{"id":"2505788865","title":"Sector Update: Health Care Stocks Decline Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2505788865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505788865?lang=en_us&edition=fundamental","pubTime":"2025-01-24 22:26","pubTimestamp":1737728817,"startTime":"0","endTime":"0","summary":"Health care stocks were declining premarket Friday as the Health Care Select Sector SPDR Fund (XLV) was down 0.4% and the iShares Biotechnology ETF (IBB) was 0.2% lower recently.Novo Nordisk (NVO) sha","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","LU1093756325.SGD","BK4139","BK4568","NVO.AU","LU1093756168.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IBB","BK4551","MRNA","BK4588","BK4007","BK4192","BK7104","BK4548","BK4599","BK4533","ALUR","NVO","BK4501","BK4581","BK4532","BK4534","XLV","BK4585"],"gpt_icon":1},{"id":"2504143671","title":"S&P 500 Gains and Losses Today: Intel Stock Soars as Takeover Speculation Spreads","url":"https://stock-news.laohu8.com/highlight/detail?id=2504143671","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504143671?lang=en_us&edition=fundamental","pubTime":"2025-01-18 06:03","pubTimestamp":1737151416,"startTime":"0","endTime":"0","summary":"The S&P 500 jumped 1% on Friday, Jan. 17, 2025, heading into a three-day weekend on a high note as prospects rebounded for additional interest-rate cuts in 2025.Intel shares took off following reports that the semiconductor giant could be an acquisition target.Freight shipper J.B. Hunt posted lower-than-expected sales and profits for the fourth quarter, and its shares dropped.Major U.S. equities indexes pushed higher to end the week, with traders set for a day off in observation of Martin Luther King Jr. Day on a Monday that will also see the swearing-in of Donald Trump for his second presidential term.The strength among stocks to close out the week coincided with rejuvenated optimism that the Federal Reserve could continue to lower interest rates in 2025, bolstered by indications of ebbing inflation. . The S&P 500 advanced 1% on Friday. Strength in the tech sector helped lift the Nasdaq 1.5%, while the Dow ended the day 0.8% higher.Eli Lilly  shares fell 4.2%, extending losses posted ","market":"nz","thumbnail":"https://www.investopedia.com/thmb/_m8hdbd-Bwhk9bdJ2TenEuGkzt8=/3744x2496/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2164837685-2cf129b9dc96463db2dba7c15b9f31a4.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/_m8hdbd-Bwhk9bdJ2TenEuGkzt8=/3744x2496/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2164837685-2cf129b9dc96463db2dba7c15b9f31a4.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/sandp-500-gains-and-losses-today-intel-soars-as-takeover-speculation-spreads-8776716","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["IE00BFTCPJ56.SGD","BK4516","LU0882574139.USD","LU0708995401.HKD","SGXZ31699556.SGD","LU1804176565.USD","LU1720051108.HKD","LU0985489474.SGD","LU0368265418.SGD","LU1057294990.SGD","FICO","ESmain","IE00BZ1G4Q59.USD","LU0256863811.USD","LU1983299246.USD","LU0203202063.USD","LU1061106388.HKD","SG9999018865.SGD","UPRO","LU0077335932.USD","NVO","BK4533","IVV","SPXU","LLY","SDS","LU0300736062.USD","BK4579","TFC","LU1489326972.SGD","INTC","LU2361044865.SGD","SH","SLB.AU","VOO","LU0096364046.USD","NVO.AU","JBHT",".SPX","SGXZ57979304.SGD","SSO","SGXZ23171101.USD","LU0353189763.USD","SPY","IE0002270589.USD","SLB","LU0820561818.USD","LU1280957306.USD","OEX","OEF"],"gpt_icon":1},{"id":"2504435118","title":"Sector Update: Health Care Stocks Softer Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2504435118","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504435118?lang=en_us&edition=fundamental","pubTime":"2025-01-18 03:00","pubTimestamp":1737140457,"startTime":"0","endTime":"0","summary":"Health care stocks declined Friday afternoon with the NYSE Health Care Index down 0.6% and the Health Care Select Sector SPDR Fund (XLV) easing 0.1%.The iShares Biotechnology ETF (IBB) rose 0.3%.In co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4198","ZLAB","BK4585","BK7104","LU1093756168.USD","BK4531","IE00BZ1G4Q59.USD","BK4548","LU1093756325.SGD","BK4139","NVO.AU","BK4532","LU0154236417.USD","BK4599","NVO","BK4581","IE00BKVL7J92.USD","IBB","BK4007","ZTEK","XLV","BK4526"],"gpt_icon":1},{"id":"2504191119","title":"Top Midday Stories: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks; Supreme Court Allows TikTok Ban to Take Effect","url":"https://stock-news.laohu8.com/highlight/detail?id=2504191119","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504191119?lang=en_us&edition=fundamental","pubTime":"2025-01-18 01:14","pubTimestamp":1737134043,"startTime":"0","endTime":"0","summary":"Wall Street's major market averages were higher around midday Friday ahead of a long Martin Luther King, Jr. holiday weekend and the inauguration of President-elect Donald Trump.In company news, Novo ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IE00B19Z3B42.SGD","SLB","LU0077335932.USD","QLD","SDOW","USAW.SI","SLB.AU","FAST","MNQmain","UDOW","DXD","DDM","IE00BFXG0V08.USD","LU1548497426.USD","IE00BZ1G4Q59.USD","TFC","LU0211331839.USD","TQQQ","LU2357305700.SGD","JBHT","NVO.AU",".DJI","NQmain","DJX","TSYW.SI","BK4532","USJW.SI","LU0208291251.USD","LU2237438978.USD","LU1489326972.SGD","SG9999004303.SGD","LU0154236417.USD","BK4211","PSQ","QID","LU0256331488.USD","SQQQ","BK4599","NVO","DOG",".IXIC","BK4022","LU0320765489.SGD","BK4007",".SPX","BK4179","NVIW.SI","LU0878866978.SGD"],"gpt_icon":1},{"id":"2504619548","title":"European Equities Traded in the US as American Depositary Receipts Edge Higher Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2504619548","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504619548?lang=en_us&edition=fundamental","pubTime":"2025-01-18 00:20","pubTimestamp":1737130858,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were edging up on Friday morning, up 0.2% to 1,328.33 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by e-commerce company MYT  and cybersecurity company WiseKey , which rose 10% and nearly 5% respectively.They were followed by semiconductor company STMicroelectronics , which was adding 2.4%.The decliners from continental Europe were led by pharmaceutical company Novo Nordisk  and biotech company Evaxion , which fell 4.3% and 3.3% respectively.From the UK and Ireland, the gainers were led by insurance provider Prudential  and cruise operator Carnival , which rose 4.2% and 3.6% respectively.The decliners from the UK and Ireland were led by cell therapy company TC Biopharm  and medical products maker Trinity Biotech , which dropped 6.1% and 3.1% respectively.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVO.AU","TRIB","IE00BZ1G4Q59.USD","IE00BMPRXN33.USD","NVO","CUK","MYTE","IE00BMPRXR70.SGD","LU1093756325.SGD","BK4554","LU0154236417.USD","BK4082","STM.AU","STM","AFG","WKEY","EVAX","BK4139","BK4585","BK4142","BK4094","PUK","IE00BKVL7J92.USD","BK4565","BK4532","BK4007","BK4599","TCBP","BK4107","BK4141","LU1093756168.USD","BK7095","BK4162","BK7104","BK4117","BK4588"],"gpt_icon":1},{"id":"2504150099","title":"Novo Nordisk Says Trial of Higher Dose Semaglutide Achieved Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2504150099","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504150099?lang=en_us&edition=fundamental","pubTime":"2025-01-17 21:07","pubTimestamp":1737119231,"startTime":"0","endTime":"0","summary":"Novo Nordisk  said Friday its phase 3b trial comparing subcutaneous semaglutide 7.2 mg with semaglutide 2.4 mg and placebo achieved its primary endpoint by demonstrating a \"statistically significant and superior\" weight loss at week 72.The trial, which involved 1,407 adults with obesity, showed participants administered with semaglutide 7.2 mg on a weekly basis alongside lifestyle interventions achieved a 20.7% weight loss from a mean baseline weight of 113 kg. This compares to a 17.5% reduction with semaglutide 2.4 mg and 2.4% with placebo.The trial demonstrated that 33.2% of participants receiving semaglutide 7.2 mg achieved at least 25% weight loss, outperforming the 16.7% with semaglutide 2.4 mg and 0% with placebo.Novo Nordisk said the semaglutide 7.2 mg demonstrated a safe and well-tolerated profile, with most adverse events being mild to moderate gastrointestinal issues that diminished over time.Novo Nordisk shares were 2.5% lower in premarket trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154236417.USD","BK4007","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4599","NVO","BK7104","LU1093756325.SGD","NVO.AU","BK4532","BK4588","LU1093756168.USD","BK4585"],"gpt_icon":1}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":157,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVO.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVO.AU\",market:\"AU\",,,undefined,":[]}}